Search Within

Nen Cao

Formats
  1. Meeting Abstract (3)
  2. Journal Article (2)
Groups
  1. Breast Medicine Service (5)
  2. Department of Medicine (5)
  3. GSK Faculty (5)
  4. Molecular Pharmacology and Chemistry Program Faculty (5)
  5. Sloan Kettering Institute Faculty (5)
  6. Sloan Kettering Institute Postdocs (5)

More Groups

People
  1. Neal Rosen (5)
  2. Sarat Chandarlapaty (4)
  3. Vanessa Rodrik - Outmezguine (4)
  4. Poulikos Poulikakos (2)
  5. Andrew Lerner Wolfe (1)
  6. Andrew Zelenetz (1)

More People

Years
  1. 2012 (1)
  2. 2011 (3)
  3. 2010 (1)
Publications
  1. Cancer Research (3)
  2. Cancer Discovery (1)
  3. Journal of Experimental Medicine (1)
Publishers
  1. American Association for Cancer Research (4)
  2. Rockefeller University Press (1)

Results (5)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • mTOR kinase inhibition relieves feedback suppression of receptor tyrosine kinase leading to a biphasic regulation of AKT signaling in breast cancer cells
    Meeting Abstract

    Rodrik-Outmezguine, V. S.; Chandarlapaty, S.; Pagano, N. C.; Poulikakos, P. I.; Scaltriti, M.; Baselga, J.; Guichard, S.; Rosen, N.
    Cancer Research (2012)

    Fulltext@MSK | Save
  • mTOR kinase inhibition relieves feedback inhibition of RTK and PI3K signaling in breast cancer cells
    Meeting Abstract

    Rodrik-Outmezguine, V. S.; Chandarlapaty, S.; Cao, N.; Smith, P.; Guichard, S.; Rosen, N.
    Cancer Research (2011)

    Fulltext@MSK | Save
  • mTOR kinase inhibition causes feedback-dependent biphasic regulation of AKT signaling
    Journal Article

    Rodrik-Outmezguine, V. S.; Chandarlapaty, S.; Pagano, N. C.; Poulikakos, P. I.; Scaltriti, M.; Moskatel, E.; Baselga, J.; Guichard, S.; Rosen, N.
    Cancer Discovery (2011)

    Fulltext@MSK | Save
  • Targeting cap-dependent translation blocks converging survival signals by AKT and PIM kinases in lymphoma
    Journal Article

    Schatz, J. H.; Oricchio, E.; Wolfe, A. L.; Jiang, M.; Linkov, I.; Maragulia, J.; Shi, W.; Zhang, Z.; Rajasekhar, V. K.; Pagano, N. C.; more...
    Journal of Experimental Medicine (2011)

    Fulltext@MSK | Save
  • AZD8055 is an effective inhibitor of mTOR kinase signaling and breast cancer growth while relieving feedback inhibition of HER-kinase signaling
    Meeting Abstract

    Rodrik - Outmezguine, V. S.; Cao, N.; Chandarlapaty, S.; She, Q. B.; Ye, Q.; Smith, P.; Guichard, S.; Rosen, N.
    Cancer Research (2010)

    Fulltext@MSK | Save